POINT PLEASANT, W. Va. -- Fruth Pharmacy has launched a new pharmacogenetic program for patients, which includes a genetics test to reduce the potential for adverse drug reactions.
According to the Point Pleasant Register, Fruth Pharmacy announced that it will now offer Rxight (“pronounced RIGHT“), described its manufacturer as the broadest, most comprehensive pharmacogenetic program. This program, developed by MD Labs, a CLIA certified high complexity laboratory, will help determine if the medications people take and the dosage levels are right for them based on their DNA. Rxight covers over 200 prescription and over-the-counter (OTC) medications.
The Rxight test provides information on medications covering 14 therapeutic classes, including pain, blood pressure, blood thinner, ADHD, anxiety, depression, diabetes, cancer, respiratory issues and other medications. It is highly likely that someone is taking one of these medications now, or will need to take them in the future.
Read more about Fruth's plans by clicking here.